Investment Q&A

• Gilead Sciences Inc. (GILD $117.18)
  • $117.18 P/E (TTM): 23.51X Cap: $144.85B
  • View GILD Profile
  • View Questions on GILD

Q: May I have your thoughts on Gileads Q 1 results and do you see the stock as a buy. Thanks.

Upvote 0

Read Answer Asked by Gerry on May 11, 2023

• MustGrow Biologics Corp - Ordinary Shares (MGRO)
  • P/E (TTM): -31.3X Cap: $140M
  • View MGRO Profile
  • View Questions on MGRO

Q: Hi. Your thoughts on this company today?

Upvote 0

Read Answer Asked by Kelly on May 10, 2023

• WELL Health Technologies Corp. (WELL $5.19)
  • $5.19 Cap: $1.46B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: WELL is down past couple of days. It's had a good run lately. Earnings I believe are coming this week. Anything to be concerned about? What do you expect?

Upvote 0

Read Answer Asked on May 09, 2023

• Inspire Medical Systems Inc. (INSP $75.17)
  • $75.17 P/E (TTM): 44.88X Cap: $2.22B
  • View INSP Profile
  • View Questions on INSP

Q: Hi, Could I get your updated take on this company? They focus on sleep apnea, which seems to be a growing medical problem. The last question about it was in 2019. Thank you, Doris

Upvote 0

Read Answer Asked by Doris on May 09, 2023

• Kenvue Inc. (KVUE $16.65)
  • $16.65 P/E (TTM): 21.44X Cap: $30.11B
  • View KVUE Profile
  • View Questions on KVUE

Q: What does your crystal ball say about this spin off company?

Upvote 0

Read Answer Asked by Christopher on May 09, 2023

• Emergent BioSolutions Inc. (EBS $9.07)
  • $9.07 P/E (TTM): 3.83X Cap: $527M
  • View EBS Profile
  • View Questions on EBS

Q: Looking for an updated view. The large short position is either very positive or very negative.

Upvote 0

Read Answer Asked by Jim on May 09, 2023

• AbCellera Biologics Inc. (ABCL $5.53)
  • $5.53 Cap: $1.74B
  • View ABCL Profile
  • View Questions on ABCL

Q: Can you me give your read on this company. It has had quite a fall and, if I am not mistaken, it initial IPO. Analysts are forecasting quite lofty price targets, however the earning forecast don't seem to be there. I do have a very small hold and I trying to decide if this would be a rare occasion where the 5i team would endorse an "average down" purchase.
Much appreciate.

Upvote 0

Read Answer Asked by Francisco on May 08, 2023

• Savaria Corporation (SIS $21.34)
  • $21.34 P/E (TTM): 28.19X Cap: $1.54B
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: what does the market expect from Savaria this week?

Upvote 0

Read Answer Asked by blake on May 08, 2023

• Butterfly Network Inc. Class A (BFLY $2.28)
  • $2.28 Cap: $646M
  • View BFLY Profile
  • View Questions on BFLY

Q: your current thoughts and future growth potential of bfly.

Upvote 0

Read Answer Asked by Ross on May 05, 2023

• Pfizer Inc. (PFE $24.78)
  • $24.78 P/E (TTM): 13.66X Cap: $143.50B
  • View PFE Profile
  • View Questions on PFE

Q: Your thoughts on the quarter? Would you pick some up at these prices?

Thanks

Dave

Upvote 0

Read Answer Asked by David on May 04, 2023

• Ocumetics Technology Corp. (OTC $1.06)
  • $1.06 Cap: $143M
  • View OTC Profile
  • View Questions on OTC

Q: 1. OTC has a design lockdown and is scheduled to begin animal trials this year.
2. It has also paid out 2 senior executives with Shares.

In your experience do you think a company letting executives go when it appears to be making progress on its research is an indicator it might be tendering a buyout? or do you think this is a sign the company is experiencing hardship and the research is not panning out?

Upvote 0

Read Answer Asked by Marjorie on May 03, 2023

• InMode Ltd. (INMD $15.27)
  • $15.27 Cap: $1.10B
  • View INMD Profile
  • View Questions on INMD

Q: Peter; What didn’t the market like of their earnings? Thanks
Rod

Upvote 0

Read Answer Asked by Rodney on May 02, 2023

• WELL Health Technologies Corp. (WELL $5.19)
  • $5.19 Cap: $1.46B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: I've lost alot of money on this stock but it is gaining back some ground.
What is the outlook for this stock? Is it a good time to purchase more?

Upvote 0

Read Answer Asked by Brenda on May 02, 2023

• Abbott Laboratories (ABT $132.57)
  • $132.57 P/E (TTM): 16.85X Cap: $232.02B
  • View ABT Profile
  • View Questions on ABT
• CVS Health Corporation (CVS $77.90)
  • $77.90 P/E (TTM): 21.46X Cap: $97.33B
  • View CVS Profile
  • View Questions on CVS
• Johnson & Johnson (JNJ $190.72)
  • $190.72 P/E (TTM): 20.29X Cap: $460.18B
  • View JNJ Profile
  • View Questions on JNJ
• Eli Lilly and Company (LLY $833.49)
  • $833.49 P/E (TTM): 55.28X Cap: $809.55B
  • View LLY Profile
  • View Questions on LLY
• Pfizer Inc. (PFE $24.78)
  • $24.78 P/E (TTM): 13.66X Cap: $143.50B
  • View PFE Profile
  • View Questions on PFE
• UnitedHealth Group Incorporated (DE) (UNH $354.50)
  • $354.50 P/E (TTM): 16.02X Cap: $333B
  • View UNH Profile
  • View Questions on UNH
• iShares Global Healthcare ETF (IXJ $90.88)
  • $90.88 P/E (TTM): 25.66X Cap: $4.01B
  • View IXJ Profile
  • View Questions on IXJ
• Health Care Select Sector SPDR (XLV $142.11)
  • $142.11 P/E (TTM): 23.15X Cap: $35.85B
  • View XLV Profile
  • View Questions on XLV

Q: I hold JNJ, PFE and CVS in the health care sector. Are JNJ and PFE sufficiently different to warrant holding both? Would you recommend an alternative (and for which one)?

Upvote 0

Read Answer Asked by Benjamin on May 01, 2023

• AbbVie Inc. (ABBV $230.50)
  • $230.50 P/E (TTM): 110.64X Cap: $407.52B
  • View ABBV Profile
  • View Questions on ABBV

Q: Hi There, would you be a buyer of ABBV right now?

Thanks,

Rob

Upvote 0

Read Answer Asked by Robert on April 27, 2023

• Lantheus Holdings Inc. (LNTH $53.54)
  • $53.54 P/E (TTM): 14.28X Cap: $3.56B
  • View LNTH Profile
  • View Questions on LNTH

Q: Peter; What are the street estimates for LNTH next week ? Thanks.
Rod

Upvote 0

Read Answer Asked by Rodney on April 27, 2023

• Eli Lilly and Company (LLY $833.49)
  • $833.49 P/E (TTM): 55.28X Cap: $809.55B
  • View LLY Profile
  • View Questions on LLY
• Thermo Fisher Scientific Inc (TMO $524.80)
  • $524.80 P/E (TTM): 31.01X Cap: $201.90B
  • View TMO Profile
  • View Questions on TMO
• UnitedHealth Group Incorporated (DE) (UNH $354.50)
  • $354.50 P/E (TTM): 16.02X Cap: $333B
  • View UNH Profile
  • View Questions on UNH

Q: I have held this stock for a few years and I am getting impatient. I guess I bought it at the wrong time, I am considering getting out. If I do exit do you have another health care company that you would recommend. Your overall thoughts please. Thanks

Upvote 0

Read Answer Asked by Brian on April 27, 2023

• AbbVie Inc. (ABBV $230.50)
  • $230.50 P/E (TTM): 110.64X Cap: $407.52B
  • View ABBV Profile
  • View Questions on ABBV

Q: Wow!!! The market really doesn't like the earnings report. Were they that bad and what is the outlook going forward. Long term holder of ABBV

Thanks Jimmy

Upvote 0

Read Answer Asked by Jimmy on April 27, 2023

• AbbVie Inc. (ABBV $230.50)
  • $230.50 P/E (TTM): 110.64X Cap: $407.52B
  • View ABBV Profile
  • View Questions on ABBV
• Johnson & Johnson (JNJ $190.72)
  • $190.72 P/E (TTM): 20.29X Cap: $460.18B
  • View JNJ Profile
  • View Questions on JNJ
• Health Care Select Sector SPDR (XLV $142.11)
  • $142.11 P/E (TTM): 23.15X Cap: $35.85B
  • View XLV Profile
  • View Questions on XLV
• iShares U.S. Medical Devices ETF (IHI $58.83)
  • $58.83 P/E (TTM): 28.17X Cap: $4.15B
  • View IHI Profile
  • View Questions on IHI

Q: the above are my healthcare holdings in my RRIF. I need to add but am wondering about eliminating individual stocks for an ETF with a higher income component. Any suggestions both on the move and the ETFS

Thanks

Upvote 0

Read Answer Asked by Tom on April 26, 2023

• Intuitive Surgical Inc. (ISRG $429.59)
  • $429.59 P/E (TTM): 62.41X Cap: $159.07B
  • View ISRG Profile
  • View Questions on ISRG

Q: At what share price would you consider buying ISRG?

Thank you,

Mike

Upvote 0

Read Answer Asked by Michael on April 26, 2023